Methemoglobinemia (DBCOND0001602)

Identifiers

Synonyms
Methaemoglobinaemia / Methemoglobinemia, unspecified / Methaemoglobinaemia NOS / Methemoglobinemia (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Methylene blue
An oxidation-reduction agent used for the treatment of pediatric and adult patients with acquired methemoglobinemia.
Methylthioninium
The phenothiazine cation in methylene blue commonly used to treat methemoglobinemia.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01766999
Methemoglobinemia After Liposuction - Diagnostic by Pulse Oximetry and Blood Gas Analysis.No drug interventionsNot AvailableNot Availablecompleted
NCT02493283
Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administrationbasic_science1completed
NCT06309641
Methemoglobinemia Following Intravenous Iron TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT03542760
Acquired Methemoglobinemia Observational RegistryNot AvailableNot Availablecompleted
NCT00993694
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneNot AvailableNot Availablecompleted
NCT01402869
Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local AnestheticsNot AvailableNot Availablecompleted
NCT02478281
Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adultstreatment1completed
NCT00960050
Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With DapsoneNo drug interventionsNot Available1unknown_status